Genetically modified human placenta-derived mesenchymal stem cells with FGF-2 and PDGF-BB enhance neovascularization in a model of hindlimb ischemia

Genetically modified human placenta-derived mesenchymal stem cells with FGF-2 and PDGF-BB enhance neovascularization in a model of hindlimb ischemia

Ischemic diseases represent a challenging worldwide health burden. The current study investigated the therapeutic potential of genetically modified human placenta-derived mesenchymal stem cells (hPDMSCs) with basic fibroblast growth factor (FGF2) and platelet-derived growth factor-BB (PDGF-BB) genes...

Full description

Bibliographic Details
Main Authors: Yin, T., He, S., Su, Chao, Chen, X., Zhang, D., Wan, Y., Ye, T., Shen, G., Wang, Y., Shi, H., Yang, L., Wei, Y.
Format: Journal Article
Published: Spandidos Publications 2015
Online Access:http://hdl.handle.net/20.500.11937/55943

Internet

http://hdl.handle.net/20.500.11937/55943

Similar Items